Driehaus Capital Management Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Investments

Industry

Estimated Revenue & Valuation

  • Driehaus Capital Management's estimated annual revenue is currently $23.6M per year.(i)
  • Driehaus Capital Management's estimated revenue per employee is $227,000

Employee Data

  • Driehaus Capital Management has 104 Employees.(i)
  • Driehaus Capital Management grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$116.6M42244%N/AN/A
#2
$8.2M45-54%N/AN/A
#3
$43.4M174-2%N/AN/A
#4
$22.5M99-1%N/AN/A
#5
$13.1M6442%N/AN/A
#6
$66.7M267-1%N/AN/A
#7
$280.3M8820%N/AN/A
#8
$11.2M55-7%N/AN/A
#9
N/A4841%N/AN/A
#10
$3.5M225%N/AN/A
Add Company

Driehaus Capital Management LLC is committed to aggressive growth investing. We consistently focus on companies that we believe have strong growth prospects, and seek to take maximum advantage of opportunities that arise in a dynamic market environment. Although our process involves much discipline, we believe it is, by design, flexible enough to react to changing market conditions. We do not mimic any external index or benchmark, nor are we restricted by strict price/earnings multiple constraints. We do, however, believe that things in motion tend to stay in motion , so we place our primary focus on the growth and quality of earnings.

keywords:N/A

N/A

Total Funding

104

Number of Employees

$23.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Driehaus Capital Management's People

NameTitleEmail/Phone
1
Manging Dir Relationship Management
2
General Counsel
3
Managing Director
4
Assistant Portfolio Manager
5
Financial Services
6
Chief Marketing Officer
7
Senior Risk Analyst
8
President & CEO
9
SVP Institutional Sales
10
Senior Program Analyst

Driehaus Capital Management News

2021-04-15 - C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform

– Cancer intelligence company, C2i Genomics announced it has raised $100M in financing from Casdin Capital, NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others. – Funds will be used to accelerate clinical development and commercialization of the company’s C2-In ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.1M10414%N/A
#2
$28.1M1041%N/A
#3
$33.6M1044%N/A
#4
$15.1M104-25%N/A
#5
$16.6M104-5%N/A